- Home
- PINS vs BMRN Comparison
PINS vs BMRN Comparison
Compare PINS & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PINS | BMRN |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 11.4B |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | PINS | BMRN |
|---|---|---|
| Price | $22.86 | $70.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 29 | 18 |
| Target Price | $26.78 | ★ $88.22 |
| AVG Volume (30 Days) | ★ 9.6M | 2.0M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | ★ $4,221,767,000.00 | $1,313,646,000.00 |
| Revenue This Year | $14.48 | $15.02 |
| Revenue Next Year | $12.04 | $12.23 |
| P/E Ratio | ★ N/A | $90.32 |
| Revenue Growth | 15.79 | ★ 17.62 |
| 52 Week Low | $13.84 | $49.26 |
| 52 Week High | $38.17 | $70.62 |
Technical Indicators
Market Signals| Indicator | PINS | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 78.73 |
| Support Level | $17.67 | $51.07 |
| Resistance Level | $24.31 | N/A |
| Average True Range (ATR) | 0.89 | 1.96 |
| MACD | -0.12 | 0.95 |
| Stochastic Oscillator | 37.00 | 90.98 |
Price Performance
Historical ComparisonAbout PINS Pinterest Inc.
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.